Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Artigo
|
![]() |
Randomised clinical trial: evaluation of the efficacy of mesalazine (mesalamine) suppositories in patients with ulcerative colitis and active rectal inflammation – a placebo‐controlled studyWatanabe, M. ; Nishino, H. ; Sameshima, Y. ; Ota, A. ; Nakamura, S. ; Hibi, T.Alimentary pharmacology & therapeutics, 2013-08, Vol.38 (3), p.264-273 [Periódico revisado por pares]Oxford: BlackwellTexto completo disponível |
2 |
Material Type: Artigo
|
![]() |
Phase I trial of pimasertib monotherapy in Japanese patients with solid tumors and those with hepatocellular carcinomaYamazaki, K. ; Doi, T. ; Ikeda, M. ; Okusaka, T. ; Schueler, A. ; Watanabe, M. ; Ohtsu, A.Cancer chemotherapy and pharmacology, 2019-11, Vol.84 (5), p.1027-1037 [Periódico revisado por pares]Berlin/Heidelberg: Springer Berlin HeidelbergTexto completo disponível |
3 |
Material Type: Artigo
|
![]() |
Genetic variations in immunomodulatory pathways to predict survival in patients with locoregional gastric cancerSunakawa, Y ; Cao, S ; Volz, N B ; Berger, M D ; Yang, D ; Parekh, A ; Zhang, W ; Matsusaka, S ; Ning, Y ; Stremitzer, S ; Stintzing, S ; Sebio, A ; Okazaki, S ; Wakatsuki, T ; Azuma, M ; Watanabe, M ; Koizumi, W ; Wu, A H ; Lenz, H-JThe pharmacogenomics journal, 2017-12, Vol.17 (6), p.528-534 [Periódico revisado por pares]United States: Nature Publishing GroupTexto completo disponível |
4 |
Material Type: Artigo
|
![]() |
Sigmoid‐vaginal fistula during bevacizumab treatment diagnosed by fistulographyHayashi, C. ; Takada, S. ; Kasuga, A. ; Shinya, K. ; Watanabe, M. ; Kano, H. ; Takayama, T.Journal of clinical pharmacy and therapeutics, 2016-12, Vol.41 (6), p.725-726 [Periódico revisado por pares]England: Hindawi LimitedTexto completo disponível |
5 |
Material Type: Artigo
|
![]() |
HET0016, a potent and selective inhibitor of 20‐HETE synthesizing enzymeMiyata, Noriyuki ; Taniguchi, Kazuo ; Seki, Takayuki ; Ishimoto, Tsuyoshi ; Sato‐Watanabe, Mariko ; Yasuda, Yoshiko ; Doi, Mariko ; Kametani, Shunichi ; Tomishima, Yasumitsu ; Ueki, Tomokazu ; Sato, Masakazu ; Kameo, KazuyaBritish journal of pharmacology, 2001-06, Vol.133 (3), p.325-329 [Periódico revisado por pares]Oxford, UK: Blackwell Publishing LtdTexto completo disponível |
6 |
Material Type: Artigo
|
![]() |
Estrogen receptor-beta genetic variations and overall survival in patients with locally advanced gastric cancerSunakawa, Y ; Cao, S ; Berger, M D ; Matsusaka, S ; Yang, D ; Zhang, W ; Ning, Y ; Parekh, A ; Stremitzer, S ; Mendez, A ; Okazaki, S ; Wakatsuki, T ; Azuma, M ; Shimada, K ; Watanabe, M ; Koizumi, W ; Wu, A H ; Lenz, H-JThe pharmacogenomics journal, 2017-01, Vol.17 (1), p.36-41 [Periódico revisado por pares]United States: Nature Publishing GroupTexto completo disponível |
7 |
Material Type: Artigo
|
![]() |
Influence of non-steroidal anti-inflammatory drugs on antiplatelet effect of aspirinYokoyama, H. ; Ito, N. ; Soeda, S. ; Ozaki, M. ; Suzuki, Y. ; Watanabe, M. ; Kashiwakura, E. ; Kawada, T. ; Ikeda, N. ; Tokuoka, K. ; Kitagawa, Y. ; Yamada, Y.Journal of clinical pharmacy and therapeutics, 2013-02, Vol.38 (1), p.12-15 [Periódico revisado por pares]Oxford, UK: Blackwell Publishing LtdTexto completo disponível |
8 |
Material Type: Artigo
|
![]() |
Sustained contraction and loss of NO production in TGF β 1 ‐treated endothelial cellsWatanabe, M ; Oike, M ; Ohta, Y ; Nawata, H ; Ito, YBritish journal of pharmacology, 2009-01, Vol.149 (4), p.355-364 [Periódico revisado por pares]Texto completo disponível |
9 |
Material Type: Artigo
|
![]() |
CYP2C19 genotype status and intragastric pH during dosing with lansoprazole or rabeprazoleAdachi, K. ; Katsube, T. ; Kawamura, A. ; Takashima, T. ; Yuki, M. ; Amano, K. ; Ishihara, S. ; Fukuda, R. ; Watanabe, M. ; Kinoshita, Y.Alimentary pharmacology & therapeutics, 2000-10, Vol.14 (10), p.1259-1266 [Periódico revisado por pares]Oxford UK: Blackwell Science LtdTexto completo disponível |
10 |
Material Type: Artigo
|
![]() |
Helicobacter pylori infection influences nocturnal gastric acid breakthroughKatsube, T. ; Adachi, K. ; Kawamura, A. ; Amano, K. ; Uchida, Y. ; Watanabe, M. ; Kinoshita, Y.Alimentary pharmacology & therapeutics, 2000-08, Vol.14 (8), p.1049-1056 [Periódico revisado por pares]Oxford UK: Blackwell Science LtdTexto completo disponível |